Generalized pustular psoriasis: the new era of treatment with IL-36 receptor inhibitors
Generalized pustular psoriasis (GPP) is a rare yet severe variant of psoriasis, characterized by the eruption of superficial sterile pustules that appear suddenly and widely distributed, potentially life-threatening. It more commonly presents through recurrent acute flares triggered by stress, corti...
Main Authors: | Cláudia Oliveira Maçães, Ana Maria Lé, Tiago Torres |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2022-10-01
|
Series: | Journal of Dermatological Treatment |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/09546634.2022.2089335 |
Similar Items
-
Exploring the Role of IL-36 Cytokines as a New Target in Psoriatic Disease
by: Helena Iznardo, et al.
Published: (2021-04-01) -
IL-1 Family Cytokines in Inflammatory Dermatoses: Pathogenetic Role and Potential Therapeutic Implications
by: Helena Iznardo, et al.
Published: (2022-08-01) -
A review of IL-36: an emerging therapeutic target for inflammatory dermatoses
by: Jonwei Hwang, et al.
Published: (2022-08-01) -
First experiences in real clinical practice treating a patient with generalised pustular psoriasis with Spesolimab
by: Aurora Fernández‐Galván, et al.
Published: (2023-06-01) -
Efficacy and Safety of Spesolimab in Patients with Generalized Pustular Psoriasis: A Subgroup Analysis of Chinese Patients in the Effisayil 1 Trial
by: Tsen-Fang Tsai, et al.
Published: (2023-10-01)